Institutional Research Cancer Epidemiology Fellowship

此申请是癌症流行病学培训计划的5年更新（39-43年）， 预防和控制（T32 CA 009314）在约翰霍普金斯彭博公共卫生学院。我们 使命是培养博士前和博士后学员成为领导者在推进知识的前沿a） 癌症的原因，包括当地、国家和地区人群中固有的和可改变的因素， B）如何预防和减少当地、国家和全球癌症负担， 交流更好地理解影响癌症发展和促进健康的行为 存活率，ii）鉴定用于癌症早期检测的新标志物，和iii）鉴定和解决癌症 差异，包括弱势群体和护理障碍;以及c）如何转化、实施和 评估癌症流行病学，预防和控制发现到人群中。我们提供丰富的， 通过高度创新、高效和协作的癌症研究增强互动环境 在公共卫生和医学学院以及西德尼·基梅尔综合癌症中心进行。 该培训计划提供癌症相关的方法学和癌症特异性实质性领域的研究 训练6名博士前和2名博士后学员学习具有共同要素的定制课程： 实质性和方法论的主题，负责任的研究行为，研究的严谨性，可重复性， 透明度;交互式信息交换;教学、交流、赠款撰写;社区外展 和参与经验;指导前或博士后研究;和癌症特定的专业 发展我们强调开发和测试新的假设和跨学科合作。经由 共享元素，学员接触当代癌症主题，如分子流行病学，大 数据、社会公正和差异、老龄化、艾滋病毒、个性化风险评估、筛查、生存率， 执行、沟通、政策。26个前受体（23%代表性不足的群体，77%认为是 因杰出辅导和癌症相关研究记录而被选中的妇女是主要辅导员。与 主任，执行委员会负责受训人员的选择/监督，和计划的完善 随着癌症研究的发展。内部和外部咨询委员会提供评估和建议。 培养时间为博士前4年，博士后2-3年。我们有一个强大的记录：43前- 和25名博士后在过去15年完成或正在培训。他们在事业上取得了成功 (89.2%研究或相关）。从大量的申请人中，最好的候选人被招募。20%来自 代表性不足的群体。总之，该计划旨在a）为学员提供多学科的 背景是进行最高水平，最先进，协作，基于人口的基础 或应用癌症研究，B）培养他们成为创新思想家，c）发展教学，沟通， 赠款写作技能，d）准备他们在学术界或其他地方领导国家的癌症研究议程。

This application is for a 5-year renewal (Years 39-43) of the Training Program in Cancer Epidemiology, Prevention, and Control (T32 CA009314) at the Johns Hopkins Bloomberg School of Public Health. Our mission is to train pre- and postdoctoral trainees to be leaders at the forefront of advancing knowledge of a) causes of cancer, including inherent and modifiable factors in human populations locally, nationally, and globally; b) how to prevent and reduce cancer burden locally, nationally, and globally by i) providing and communicating a better understanding of behaviors that influence cancer development and promote healthy survivorship, ii) identifying new markers for early detection of cancer, and iii) identifying and addressing cancer disparities including in vulnerable populations and barriers to care; and c) how to translate, implement, and evaluate cancer epidemiology, prevention, and control discoveries into populations. We provide a rich and interactive environment augmented by highly innovative, productive, and collaborative cancer research conducted at the Schools of Public Health and Medicine and Sidney Kimmel Comprehensive Cancer Center. The Training Program provides cancer-relevant methodologic and cancer-specific substantive area research training. 6 pre- and 2 postdoctoral trainees pursue tailored curricula with shared elements: didactic courses on substantive and methodologic topics, responsible conduct of research, research rigor, reproducibility, and transparency; interactive information exchange; teaching, communication, grant writing; community outreach and engagement experience; mentored pre- or postdoctoral research; and cancer-specific professional development. We stress developing and testing novel hypotheses and collaborating across disciplines. Via shared elements, trainees are exposed to contemporary cancer topics such as molecular epidemiology, big data, social justice and disparities, aging, HIV, personalized risk assessment, screening, survivorship, implementation, communication, policy. 26 Preceptors (23% underrepresented groups, 77% identify as women), selected for outstanding mentoring and cancer-relevant research records, are primary mentors. With the Director, the Executive Committee is responsible for trainee selection/monitoring, and program refinement as cancer research evolves. Internal and External Advisory Committees provide evaluation and advice. Training duration is 4 years for pre- and 2-3 years for postdoctoral trainees. We have a strong record: 43 pre- and 25 postdoctoral trainees in the last 15 years completed or are in training. They have had career success (89.2% research or related). From a large pool of applicants, the best candidates are recruited. 20% are from underrepresented groups. In summary, the Program is designed to a) provide trainees with a multidisciplinary background essential to conduct highest caliber, state-of-the-art, collaborative, population-based foundational or applied cancer research, b) nurture them to be innovative thinkers, c) develop teaching, communication, grant-writing skills, d) prepare them to lead the nation's cancer research agenda in academia or elsewhere.